Verastem Inc. plans to raise about $43.0 million through an offering of 7,166,666 of its common shares at $6.00 apiece.

The shares were offered to funds managed by healthcare-focused private equity firm Consonance Capital Partners LP.

The offering is expected to close June 18, subject to customary closing conditions.

Needham, Mass.-based Verastem is a biopharmaceutical company which focuses on discovering and developing cancer drugs.